Trial
NCT06588660
ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Simcha Therapeutics
Condition
Recurrent Multiple Myeloma
Intervention
Vevoctadekin
Why stopped
Study terminated due to end of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-29